Personal information

No personal information available

Activities

Collapse all

Works (3)

Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study

Annals of Hematology
2024-03 | Journal article
DOI: 10.1007/s00277-023-05572-0
Contributors: Ivo Demel; David Skopal; Eliška Šafránková; Petra Rozsívalová; Pavel Jindra; Jiří Šrámek; Adéla Turková; Jan Vydra; Klára Labská; Jana Vedrová et al.
Source: check_circle
Crossref

Natural killer cells: Innate immune system as a part of adaptive immunotherapy in hematological malignancies

American Journal of Hematology
2022-06 | Journal article
DOI: 10.1002/ajh.26529
Contributors: Ivo Demel; Zdenek Koristek; Benjamin Motais; Roman Hajek; Tomas Jelinek
Source: check_circle
Crossref

Focus on monoclonal antibodies targeting B‐cell maturation antigen (BCMA) in multiple myeloma: update 2021

British Journal of Haematology
2021-05 | Journal article
DOI: 10.1111/bjh.17235
Contributors: Ivo Demel; Julio Rodriguez Bago; Roman Hajek; Tomas Jelinek
Source: check_circle
Crossref
How many people are using ORCID?